Q4 2024 · 13F-HR
Ikarian Capital, LLCholdings as filed
Filed 2025-02-14 · accession 0001420506-25-000610
$735.3M
Reported value
171
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR SER TR | $67.5M | 9.19% | 750,000 | PUT | SOLE |
| 78464A870 | XBI | SPDR SER TR | $63.0M | 8.57% | 700,000 | CALL | SOLE |
| 902494103 | TSN | TYSON FOODS INC | $36.2M | 4.92% | 630,000 | PUT | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $33.6M | 4.58% | 607,689 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $26.4M | 3.59% | 516,431 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $19.3M | 2.62% | 74,000 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $19.2M | 2.61% | 700,000 | CALL | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $15.4M | 2.10% | 357,185 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $14.8M | 2.01% | 169,374 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $13.8M | 1.88% | 609,225 | Common | SOLE |
| 72147K108 | PPC | PILGRIMS PRIDE CORP | $13.6M | 1.85% | 300,000 | PUT | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $11.6M | 1.58% | 400,000 | PUT | SOLE |
| 457669307 | INSM | INSMED INC | $10.4M | 1.41% | 150,000 | CALL | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $9.8M | 1.34% | 81,000 | CALL | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $9.5M | 1.30% | 900,000 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $9.0M | 1.23% | 469,949 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $8.9M | 1.21% | 394,538 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $8.8M | 1.19% | 291,240 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $8.5M | 1.15% | 100,000 | CALL | SOLE |
| 457669307 | INSM | INSMED INC | $8.3M | 1.12% | 119,800 | Common | SOLE |
| 128030202 | CALM | CAL MAINE FOODS INC | $7.7M | 1.05% | 75,000 | PUT | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $7.7M | 1.05% | 284,085 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $7.6M | 1.03% | 769,700 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $7.5M | 1.02% | 178,989 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $7.4M | 1.01% | 300,000 | CALL | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $7.3M | 0.99% | 349,649 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $7.2M | 0.98% | 970,259 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $7.1M | 0.96% | 149,982 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $6.6M | 0.90% | 280,800 | PUT | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $6.6M | 0.90% | 897,862 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $6.6M | 0.89% | 142,328 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $6.6M | 0.89% | 282,159 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $5.9M | 0.81% | 215,713 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $5.7M | 0.78% | 576,166 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $5.6M | 0.77% | 378,363 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $5.5M | 0.75% | 199,000 | PUT | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $5.5M | 0.75% | 29,800 | CALL | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $5.5M | 0.75% | 152,211 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $5.3M | 0.72% | 720,300 | CALL | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $5.2M | 0.71% | 205,500 | PUT | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $5.0M | 0.68% | 361,100 | CALL | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $4.6M | 0.63% | 1,126,637 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $4.5M | 0.61% | 755,867 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $4.4M | 0.60% | 102,100 | CALL | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $4.3M | 0.59% | 149,502 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $4.2M | 0.57% | 857,230 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $4.2M | 0.57% | 100,000 | PUT | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $4.1M | 0.56% | 34,087 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $4.1M | 0.56% | 300,000 | PUT | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $4.1M | 0.56% | 373,265 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $4.1M | 0.56% | 310,800 | PUT | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.1M | 0.56% | 332,390 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $4.1M | 0.56% | 52,216 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $4.0M | 0.55% | 754,400 | CALL | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.0M | 0.54% | 74,691 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $3.7M | 0.51% | 80,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $3.7M | 0.50% | 350,000 | PUT | SOLE |
| 23256X407 | HELP | CYBIN INC | $3.5M | 0.48% | 397,175 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $3.4M | 0.46% | 200,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.4M | 0.46% | 75,000 | PUT | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $3.4M | 0.46% | 175,100 | CALL | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $3.3M | 0.45% | 250,000 | CALL | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $3.3M | 0.45% | 499,301 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $3.0M | 0.40% | 533,581 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $2.9M | 0.40% | 100,000 | CALL | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.9M | 0.39% | 693,308 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $2.8M | 0.38% | 221,911 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $2.7M | 0.37% | 70,000 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $2.7M | 0.36% | 500,000 | PUT | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $2.6M | 0.35% | 64,300 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $2.4M | 0.33% | 292,772 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $2.4M | 0.33% | 62,052 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $2.4M | 0.33% | 300,000 | CALL | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $2.4M | 0.33% | 1,092,590 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $2.2M | 0.30% | 100,000 | CALL | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $2.2M | 0.30% | 253,754 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $2.2M | 0.29% | 311,575 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $2.1M | 0.29% | 676,608 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $2.1M | 0.29% | 141,000 | CALL | SOLE |
| 415858109 | HROW | HARROW INC | $2.0M | 0.27% | 58,300 | CALL | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $2.0M | 0.27% | 450,000 | Common | SOLE |
| 800677106 | SGMO | SANGAMO THERAPEUTICS INC | $1.9M | 0.26% | 1,860,179 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.9M | 0.26% | 2,029,028 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $1.9M | 0.25% | 350,489 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.8M | 0.24% | 950,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.7M | 0.23% | 308,491 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $1.7M | 0.23% | 431,100 | PUT | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.6M | 0.22% | 1,441,141 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $1.6M | 0.22% | 1,614,170 | Common | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $1.5M | 0.21% | 1,200,000 | CALL | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $1.5M | 0.21% | 1,200,000 | PUT | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $1.5M | 0.20% | 350,000 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $1.5M | 0.20% | 599,913 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $1.4M | 0.20% | 53,940 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.4M | 0.19% | 67,927 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $1.4M | 0.18% | 37,519 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $1.3M | 0.18% | 325,000 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.2M | 0.16% | 100,365 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $1.2M | 0.16% | 300,000 | CALL | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.2M | 0.16% | 165,700 | PUT | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.2M | 0.16% | 165,700 | CALL | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $1.2M | 0.16% | 55,107 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.2M | 0.16% | 971,950 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $1.1M | 0.16% | 1,550,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.1M | 0.15% | 466,030 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $1.1M | 0.14% | 650,000 | CALL | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $1.0M | 0.14% | 100,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $958,748 | 0.13% | 169,991 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $956,675 | 0.13% | 613,253 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $940,452 | 0.13% | 200,096 | Common | SOLE |
| 816212302 | RNAC | CARTESIAN THERAPEUTICS INC | $934,294 | 0.13% | 52,166 | Common | SOLE |
| 68232V884 | TRAW | TRAWS PHARMA INC | $874,618 | 0.12% | 98,493 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $868,001 | 0.12% | 350,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $850,000 | 0.12% | 500,000 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $834,000 | 0.11% | 60,000 | Common | SOLE |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $816,664 | 0.11% | 1,276,037 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $815,000 | 0.11% | 500,000 | PUT | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $766,939 | 0.10% | 202,894 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $760,486 | 0.10% | 201,187 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $718,375 | 0.10% | 106,901 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $659,116 | 0.09% | 34,985 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $651,962 | 0.09% | 892,976 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $648,679 | 0.09% | 42,122 | Common | SOLE |
| 00808Y406 | AEMDEUR | AETHLON MED INC | $645,001 | 0.09% | 750,000 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $635,800 | 0.09% | 635,800 | CALL | SOLE |
| 92536C103 | VERUEUR | VERU INC | $614,878 | 0.08% | 945,239 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $606,885 | 0.08% | 51,431 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $603,533 | 0.08% | 78,585 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $594,949 | 0.08% | 365,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $536,324 | 0.07% | 91,994 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $457,123 | 0.06% | 265,769 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $436,329 | 0.06% | 62,691 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $420,000 | 0.06% | 1,000,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $393,692 | 0.05% | 22,600 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $388,222 | 0.05% | 690,050 | Common | SOLE |
| 16385C104 | — | CHEMOMAB THERAPEUTICS LTD | $385,624 | 0.05% | 213,052 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $362,050 | 0.05% | 65,000 | CALL | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $345,476 | 0.05% | 108,300 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $341,968 | 0.05% | 107,200 | PUT | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $318,546 | 0.04% | 649,963 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $316,194 | 0.04% | 55,766 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $315,159 | 0.04% | 175,088 | Common | SOLE |
| 05360L403 | ATXI | AVENUE THERAPEUTICS INC | $280,000 | 0.04% | 140,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $276,539 | 0.04% | 408,899 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $264,971 | 0.04% | 157,720 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $260,232 | 0.04% | 80,071 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $228,968 | 0.03% | 77,616 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $226,496 | 0.03% | 58,526 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $221,863 | 0.03% | 83,407 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $218,403 | 0.03% | 1,058,148 | Common | SOLE |
| 74907L300 | — | QUOIN PHARMACEUTICALS LTD | $178,942 | 0.02% | 275,000 | Common | SOLE |
| 00791X100 | — | AEON BIOPHARMA INC | $139,085 | 0.02% | 257,563 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $129,976 | 0.02% | 5,908 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $114,685 | 0.02% | 3,594 | Common | SOLE |
| 43906K209 | HOOK | HOOKIPA PHARMA INC | $106,522 | 0.01% | 52,996 | Common | SOLE |
| 87978U108 | OVASUSD | TEMPEST THERAPEUTICS INC | $87,860 | 0.01% | 105,285 | Common | SOLE |
| 05330T205 | AMIX | AUTONOMIX MED INC | $75,200 | 0.01% | 20,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $74,982 | 0.01% | 6,798 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $53,929 | 0.01% | 11,984 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $31,248 | 0.00% | 3,600 | PUT | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $31,248 | 0.00% | 3,600 | CALL | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $27,978 | 0.00% | 20,422 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $20,940 | 0.00% | 40,270 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $14,862 | 0.00% | 600 | Common | SOLE |
| 10501E300 | BCLI | BRAINSTORM CELL THERAPEUTICS | $13,657 | 0.00% | 6,016 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $12,151 | 0.00% | 1,400 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $9,192 | 0.00% | 8,924 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5,340 | 0.00% | 200 | PUT | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $1,619 | 0.00% | 6,501 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $223 | 0.00% | 40 | Common | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $129 | 0.00% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.